Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,364 | -31,154 | -22,709 | -14,346 | -5,999 |
| Depreciation Amortization | 23 | 77 | 17 | 8 | N/A |
| Accounts payable and accrued liabilities | -509 | 917 | 638 | 523 | 2,018 |
| Other Working Capital | -3,470 | 5,506 | 4,013 | 1,639 | 1,626 |
| Other Operating Activity | 1,676 | 2,337 | 1,669 | 755 | -1,416 |
| Operating Cash Flow | $-8,644 | $-22,317 | $-16,372 | $-11,421 | $-3,771 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -102,122 | -21,881 | -27,966 | -11,080 | -10,556 |
| PPE Investments | -1 | -125 | -125 | -125 | -2 |
| Investing Cash Flow | $-102,123 | $-22,006 | $-28,091 | $-11,205 | $-10,558 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 265 | 173,805 | 38,278 | 38,278 | 3,399 |
| Financing Cash Flow | $265 | $173,805 | $38,278 | $38,278 | $3,399 |
| Beginning Cash Position | 148,627 | 19,145 | 19,145 | 19,145 | 19,145 |
| End Cash Position | 38,125 | 148,627 | 12,960 | 34,797 | 8,215 |
| Net Cash Flow | $-110,502 | $129,482 | $-6,185 | $15,652 | $-10,930 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,644 | -22,317 | -16,372 | -11,421 | -3,771 |
| Capital Expenditure | -1 | -125 | -125 | -125 | -2 |
| Free Cash Flow | -8,645 | -22,442 | -16,497 | -11,546 | -3,773 |